Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19

NCT04373135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1971

Last updated 2025-01-30

No results posted yet for this study

Summary

The novel coronavirus (COVID-19) is affecting the way many people live their lives, including seeking medical care and maintaining good self-care to keep healthy. Additionally, in the event many people become critically ill at once, COVID-19 has the possibility of overwhelming hospitals to the point where they have to make decisions about how to determine who receives intensive care and life-support measures. Many hospitals as well as local or state governments have been working on policies to determine how to make these decisions. This study seeks to learn about how COVID-19 has affected the way patients and healthcare providers care for themselves and about their thoughts and concerns about policies that may "ration" life-support resources.

Conditions

  • Covid-19
  • Critical Illness
  • Attitude of Health Personnel
  • Attitude to Health
  • Health Behavior
  • Health Care Utilization

Interventions

BEHAVIORAL

Brief educational video

A brief educational video will be displayed explaining the mechanics of how SRA policies operate, how they are decided, and what patients' and healthcare workers' rights are surrounding them.

Sponsors & Collaborators

Principal Investigators

  • Russell G Buhr, MD, PhD · Division of Pulmonary & Critical Care Medicine, UCLA

  • Lauren E Wisk, PhD · Division of General Internal Medicine & Health Services Research, UCLA

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-08
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04373135 on ClinicalTrials.gov